Changes in Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio During Palliative Radiotherapy May Predict Efficacy of Immune Checkpoint Inhibitor as Re-Challenge Treatment in Advanced Gastric Cancer: A Case Report.

Chen, Jianxin; Wu, Xilin; Zhu, Shijian; Wang, Junhui

Chen, Jianxin; Wu, Xilin; Zhu, Shijian; Wang, Junhui.

Affiliation

Chen J; The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
Wu X; The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
Zhu S; The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
Wang J; The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.

Front Oncol ; 12: 873213, 2022.

Article de En | MEDLINE | ID: mdl-35664734

Mots clés

gastric cancer; lymphocyte to monocyte ratio; neutrophil to lymphocyte ratio; programmed death-1 inhibitor; re-challenge

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Front Oncol Année: 2022 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google